Harvard Bioscience
HBIO
#10165
Rank
A$29.56 M
Marketcap
A$0.67
Share price
-4.15%
Change (1 day)
-38.29%
Change (1 year)

Earnings for Harvard Bioscience (HBIO)

Earnings in 2025 (TTM): -A$85.57 Million

According to Harvard Bioscience's latest financial reports the company's current earnings are A$87.37 Million. In 2024 the company made an earning of -A$16.49 Million a decrease over its 2023 earnings that were of -A$3.62 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harvard Bioscience from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$85.57 Million419.11%
2024 -A$16.49 Million356.38%
2023 -A$3.62 Million-72.15%
2022 -A$12.98 Million6456.43%
2021 -A$0.2 Million-98.08%
2020 -A$10.31 Million32.53%
2019 -A$7.78 Million-31.01%
2018 -A$11.27 Million243.9%
2017 -A$3.28 Million-24.66%
2016 -A$4.35 Million-14.69%
2015 -A$5.1 Million-181.68%
2014 A$6.24 M-9.97%
2013 A$6.93 M120%
2012 A$3.15 M-50.9%
2011 A$6.41 M-52.51%
2010 A$13.51 M-2.53%
2009 A$13.86 M28.26%
2008 A$10.81 M-20.05%
2007 A$13.52 M13.96%
2006 A$11.86 M17.59%
2005 A$10.08 M57.37%
2004 A$6.41 M-37.31%
2003 A$10.22 M208.03%
2002 A$3.31 M-168.71%
2001 -A$4.84 Million-66.89%
2000 -A$14.6 Million